Patients with vs without keloids had a higher prevalence of interstitial lung disease after controlling for patient specific factors.

A panel of experts, including Dr Rohit Aggarwal, Principal Investigator of the decentralized Myositis Interstitial Lung ...

Patients with vs without rheumatoid arthritis (RA), especially those with RA-associated interstitial lung disease (RA-ILD), have a significantly higher risk of developing lung cancer, according to ...

The following is a summary of “Evaluating sensitization-associated, neuropathic-like symptoms and psychological factors in ...

Merck and Daiichi Sankyo's HER3 antibody-drug conjugate reported a positive phase 3 result in EGFR-mutated lung cancer. Merck ...

National Youth Tobacco Survey e-cigarette and nicotine pouch data from the U.S. Food and Drug Administration (FDA) and the ...

Merck reported topline data from its HERTHENA-Lung02 phase 3 trial of patritumab deruxtecan in EGFR-mutated non-small cell ...

The Phase III trial evaluating nerandomilast as a treatment for idiopathic pulmonary fibrosis met its primary endpoint.

Findings of a systematic review highlight the need for standardized assessment tools and targeted treatments for chronic ...

Diffuse (interstitial) lung disease includes a wide variety of relatively uncommon conditions presenting with characteristic clusters of clinical features and marked by an immune response.

The American Lung Association in Virginia announced the start of its 2025-2026 research awards and grants cycle at the end of ...